Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei You

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Expert Review of Gastroenterology & Hepatology|August 28, 2018
Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patientsLing-Yun Zhao, Rong-Rui Huo, Xiao Xiang, et al.
Medicine|November 13, 2015
Randomized Clinical Trial Comparing Efficacy of Simo Decoction and Acupuncture or Chewing Gum Alone on Postoperative Ileus in Patients With Hepatocellular Carcinoma After HepatectomyXue-Mei You, Xin-Shao Mo, Liang Ma, et al.
Cellular Signalling|January 21, 2023
Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing the polarization of macrophages in adipose tissueQing Zhou, Yuyan Wang, Zongshi Lu, et al.
Journal of Advanced Research|May 14, 2024
Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expressionYu Zhao, Zongshi Lu, Hexuan Zhang, et al.
Obesity (Silver Spring, Md.)|March 9, 2023
Mitochondrial dysfunction caused by SIRT3 inhibition drives proinflammatory macrophage polarization in obesityQing Zhou, Yuyan Wang, Zongshi Lu, et al.
International Journal of Biological Sciences|June 16, 2025
Endothelial SIRT3 deficiency predisposes brown adipose tissue to whitening in diet-induced obesityQing Zhou, Zongshi Lu, Bowen Wang, et al.
Hepatology (Baltimore, Md.)|February 5, 2025
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesDa-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Expert Review of Gastroenterology & Hepatology|August 28, 2018
Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patientsLing-Yun Zhao, Rong-Rui Huo, Xiao Xiang, et al.
Medicine|November 13, 2015
Randomized Clinical Trial Comparing Efficacy of Simo Decoction and Acupuncture or Chewing Gum Alone on Postoperative Ileus in Patients With Hepatocellular Carcinoma After HepatectomyXue-Mei You, Xin-Shao Mo, Liang Ma, et al.
Cellular Signalling|January 21, 2023
Cx43 acts as a mitochondrial calcium regulator that promotes obesity by inducing the polarization of macrophages in adipose tissueQing Zhou, Yuyan Wang, Zongshi Lu, et al.
Journal of Advanced Research|May 14, 2024
Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expressionYu Zhao, Zongshi Lu, Hexuan Zhang, et al.
Obesity (Silver Spring, Md.)|March 9, 2023
Mitochondrial dysfunction caused by SIRT3 inhibition drives proinflammatory macrophage polarization in obesityQing Zhou, Yuyan Wang, Zongshi Lu, et al.
International Journal of Biological Sciences|June 16, 2025
Endothelial SIRT3 deficiency predisposes brown adipose tissue to whitening in diet-induced obesityQing Zhou, Zongshi Lu, Bowen Wang, et al.
Hepatology (Baltimore, Md.)|February 5, 2025
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesDa-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Pageof 13